Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Intellia Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 291
- −13 vs. Q4 2022
- Shares held
- 78.7M
- +714.9K (+0.9%) vs. Q4 2022
- Total value
- $2.93B
- +$207.8M (+7.6%) vs. Q4 2022
- New holders
- 34
- 107 more added
- Sold out
- 47
- 91 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Man Group plc | 0 | $0 | 0.00% | −30,465−100.0% | Sold out |
| Echo Street Capital Management LLC | 0 | $0 | 0.00% | −22,392−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −16,401−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,152−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −14,768−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −14,355−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −13,464−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −13,192−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,168−100.0% | Sold out |
| Yorktown Management & Research Co Inc | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,633−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −10,383−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −9,982−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −9,767−100.0% | Sold out |
| Utah Retirement Systems | 0 | $0 | 0.00% | −9,400−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −9,387−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −7,964−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −7,753−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −7,308−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −1,550−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −762−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −480−100.0% | Sold out |
| Arcus Capital Partners, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −228−100.0% | Sold out |
| Romano Brothers and Company | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Leelyn Smith, LLC | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Estabrook Capital Management | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Yarbrough Capital, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Affiance Financial, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| J.Safra Asset Management Corp | 0 | $0 | 0.00% | −11−100.0% | Sold out |